SCHEMBL6602962

SCHEMBL6602962

COc1ccc(C(=O)Nc2ccc3c(c2Cl)CNCC3)cc1Br

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
KDM4E B2RXH2 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C19 P33261 1/20 0.55
KMT2A Q03164 8/20 0.44
MEN1 O00255 6/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
ROCK2 O75116 2/20 0.43
PRKG1 Q13976 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602268 0.89 MAPT (0.49) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL6604270 0.88 KCNQ3 (0.47) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL5874163 0.86 MAPT (0.53) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL6602306 0.85 MAPT (0.45) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL6604412 0.81 NPC1 (0.52) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL8120517 0.80 NPC1 (0.46) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL5874093 0.80 MAPT (0.50) MAPTKDM4ECYP1A2CYP3A4CYP2C19
SCHEMBL6601449 0.80 TOP2A (0.42) HDAC1HDAC8HDAC6ROCK2PRKG1
SCHEMBL6600619 0.79 CREBBP (0.46) MAPTKDM4ECYP3A4KMT2AMEN1
SCHEMBL6601241 0.78 MAPT (0.44) MAPTKDM4ECYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP claimed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US claimed
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP disclosed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US disclosed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP disclosed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO disclosed